尔湾华人论坛

Rucaparib is a targeted cancer therapy belonging to the class of PARP inhibitors, primarily used in the treatment of ovarian, fallopian tube, and peritoneal cancers, particularly in patients with BRCA mutations. It works by blocking the PARP enzyme, which helps repair damaged DNA in cancer cells ...